Trials / Conditions / Trypanosomiasis, African

Trypanosomiasis, African

14 registered clinical trials studyying Trypanosomiasis, African.

Status	Trial	Sponsor	Phase
Withdrawn	Screen and Treat Implementation for HAT Control NCT05645822	Institute of Tropical Medicine, Belgium	—
Completed	DDI Study of Single Oral Dose of Acoziborole With Sequential Co-administration of Midazolam and Dextromethorph NCT05947604	Drugs for Neglected Diseases	Phase 1
Completed	Pharmacokinetic, Efficacy, Safety and Tolerability Study of a Single Dose of Acoziborole in g-HAT Paediatric P NCT05433350	Drugs for Neglected Diseases	Phase 2 / Phase 3
Completed	Safety and Tolerability Study of Acoziborole in g-HAT Seropositive Subjects NCT05256017	Drugs for Neglected Diseases	Phase 2 / Phase 3
Completed	Fexinidazole in Human African Trypanosomiasis Due to T. b. Rhodesiense NCT03974178	Drugs for Neglected Diseases	Phase 2 / Phase 3
Completed	Fexinidazole in Human African Trypanosomiasis Due to T.b. Gambiense at Any Stage NCT03025789	Drugs for Neglected Diseases	Phase 3
Completed	Efficacy and Safety of Acoziborole (SCYX-7158) in Patients With Human African Trypanosomiasis Due to T.b. Gamb NCT03087955	Drugs for Neglected Diseases	Phase 2 / Phase 3
Completed	Bioequivalence Study - Reference Clinical Fexinidazole Tablet Versus Proposed Market Formulation NCT02571062	Drugs for Neglected Diseases	Phase 1
Completed	Human African Trypanosomiasis: First in Man Clinical Trial of a New Medicinal Product, the SCYX-7158 NCT01533961	Drugs for Neglected Diseases	Phase 1
Terminated	Multiple Dose Study to Evaluate Security, Tolerance and Pharmacokinetic of Fexinidazole (Drug Candidate for Hu NCT01483170	Drugs for Neglected Diseases	Phase 1
Terminated	Eflornithine + Nifurtimox Late-Stage Human African Trypanosomiasis (HAT)in West Nile, Uganda NCT00489658	Epicentre	Phase 2 / Phase 3
Completed	A Trial of DB289 for the Treatment of Stage I African Trypanosomiasis NCT00802594	Immtech Pharmaceuticals, Inc	Phase 2
Terminated	Randomized Clinical Trial of Three Drug Combinations for Late-Stage Gambiense Human African Trypanosomiasis NCT00330148	Epicentre	Phase 3
Completed	Efficacy - Safety of Eflornithine-Nifurtimox Combination Versus Eflornithine to Treat Human African Trypanosom NCT00146627	Drugs for Neglected Diseases	Phase 3